FDA Inspection 1116277 — Amber G. Hatch, M.D.
The FDA completed an inspection of Amber G. Hatch, M.D. on December 3, 2019 in Winston Salem, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 3, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Winston Salem, NC (United States)
Additional Details
Clinical Investigator (CI)